STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Globe Life Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Dolores L. Skarjune, Executive Vice President and Chief Administrative Officer of Globe Life Inc. (GL), reported multiple transactions dated 09/10/2025. She exercised an employee stock option to acquire 6,200 shares at an exercise price of $103.23 per share. On the same date she sold 3,354 shares at prices ranging from $139.31 to $140.01 and sold an additional 1,620 shares at prices ranging from $140.015 to $140.49. After these transactions she beneficially owned 11,037 shares directly and 2,701.527 shares indirectly through a 401(k) plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.

Positive
  • Option exercise disclosed: Acquisition of 6,200 shares via employee stock option at $103.23 is fully reported
  • Clear post-transaction ownership: Direct beneficial ownership of 11,037 shares and indirect 2,701.527 shares via 401(k) are stated
Negative
  • Partial share dispositions: Sales totaling 4,974 shares were executed at prices between $139.31 and $140.49
  • Price breakdown not itemized: The filing provides sale price ranges and notes per-price allocation is available only upon request

Insights

TL;DR: Routine insider option exercise paired with partial share sales; net holdings remain disclosed and typical for Section 16 reporting.

The filing shows an option exercise for 6,200 shares at $103.23 and contemporaneous sales totaling 4,974 shares at market prices (~$139.31–$140.49). These transactions are disclosed under Section 16 and do not by themselves provide new operational or financial information about Globe Life. The filing clearly reports post-transaction direct ownership of 11,037 shares and indirect ownership of 2,701.527 shares through a 401(k) plan, satisfying beneficial ownership reporting requirements.

TL;DR: Disclosure appears complete for the reported transactions and adheres to Form 4 requirements.

The Form 4 identifies the reporting person, role (EVP and Chief Administrative Officer), transaction dates, option exercise details, sale ranges, and resulting beneficial ownership. The explanatory footnotes specify the sale price ranges and offer to provide per-price allocation upon request, which aligns with common practice when multiple sale prices occur. There is no indication of amendments or missing mandatory fields in the provided content.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Skarjune Dolores L

(Last) (First) (Middle)
C/O GLOBE LIFE INC.
3700 SOUTH STONEBRIDGE DRIVE

(Street)
MCKINNEY TX 75070

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GLOBE LIFE INC. [ GL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and Chief Admin. Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/10/2025 M 6,200 A $103.23 14,391 D
Common Stock 09/10/2025 S 3,354 D $139.6794(1)(2) 11,037 D
Common Stock 09/10/2025 S 1,620 D $140.1556(2)(3) 9,417 D
Common Stock 2,701.527 I 401(K) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $103.23 09/10/2025 M 6,200 02/23/2025 02/23/2029 Common Stock 6,200 $0 3,550 D
Explanation of Responses:
1. Sales at prices ranging from $139.31 per share to $140.01 per share.
2. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
3. Sales at prices ranging from $140.015 per share to $140.49 per share.
Dolores L. Skarjune by Chris T. Moore, Attorney-in-fact 09/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did GL insider Dolores Skarjune report on Form 4?

The filing reports an exercise of 6,200 option shares at $103.23 and sales of 3,354 and 1,620 shares on 09/10/2025 at prices ranging from $139.31 to $140.49.

How many Globe Life (GL) shares does Dolores Skarjune beneficially own after the reported transactions?

The Form 4 states 11,037 shares are beneficially owned directly and 2,701.527 shares are held indirectly through a 401(k) plan.

What was the exercise price for the employee stock option reported by the GL insider?

The employee stock option was exercised at an exercise price of $103.23 per share.

Are the exact sale prices for each share disclosed in the Form 4?

No; the filing provides sale price ranges ($139.31–$140.01 and $140.015–$140.49) and states the reporting person will provide per-price allocations upon request.

When were these transactions executed according to the Form 4?

All reported transactions have a transaction date of 09/10/2025 and the form was signed on 09/11/2025.
Globe Life Inc

NYSE:GL

GL Rankings

GL Latest News

GL Latest SEC Filings

GL Stock Data

10.58B
80.46M
0.61%
85.78%
2.02%
Insurance - Life
Life Insurance
Link
United States
MCKINNEY